Why is Link Pharma Chem falling/rising?

As of 03-Sep, Link Pharma Chem Ltd's stock price is currently at Rs 35.00, reflecting an increase of Rs 1.0 or 2.94%. Today's performance indicates that the stock has outperformed its sector by 1.58%, reaching an intraday high of Rs 36.38, which is a 7% increase. However, despite this short-term gain, the stock has shown a negative trend over the past month with a decline of 4.27% and a significant year-to-date drop of 14.63%. The company faces challenges, including a weak long-term fundamental strength with a -183.49% CAGR growth in operating profits over the last five years and a poor EBIT to interest ratio of 0.79, indicating difficulties in servicing its debt. Additionally, the stock has generated a return of -18.98% over the past year, while profits have decreased by 69%, contributing to a perception of risk among investors.
In the broader market context, Link Pharma Chem's recent performance contrasts with the Sensex, which has shown a slight decline of 0.27% over the past week. While the stock has outperformed the sector today, its long-term performance remains below par, with underperformance against the BSE500 over the last three years, one year, and three months. The falling investor participation, as evidenced by a 39.39% decrease in delivery volume, suggests waning interest, which could further pressure the stock despite its recent uptick. Overall, while there is a short-term rise in price, the underlying fundamentals and broader market trends indicate significant challenges ahead for Link Pharma Chem Ltd.